Advocates, Medical Professionals, Patient Organizations, Researchers, Legislative Advocacy, Research & Drug Development, PDF, Research, September 28, 2022 Impact of the Orphan Drug Tax Credit
Advocates, Medical Professionals, Researchers, Legislative Advocacy, Research & Drug Development, PDF, Research, FDA’s Accelerated Approval Pathway: A Rare Disease Perspective
Medical Professionals, Students & Volunteers, Understanding Rare Disease, Collection, Education, Continuing Medical Education (CME)
Advocates, Medical Professionals, Patient Organizations, Researchers, Students & Volunteers, Research & Drug Development, PDF, Research, Orphan Drugs in the U.S.: An Examination of Patents and Orphan Drug Exclusivity
Advocates, Medical Professionals, Patient & Caregiver, Patient Organizations, Researchers, Students & Volunteers, Diversity, Equity & Inclusion, Get Involved, Understanding Rare Disease, PDF, Education, Research, Ensuring Access to Telehealth for Rare Disease
Advocates, Medical Professionals, Patient Organizations, Students & Volunteers, Legislative Advocacy, Research & Drug Development, PDF, Research, Orphan Drugs in the U.S.: Exclusivity, Pricing and Treated Populations
Advocates, Medical Professionals, Patient Organizations, Researchers, Students & Volunteers, Research & Drug Development, PDF, Research, Orphan Drug Trends in the U.S. in 2018
Advocates, Medical Professionals, Researchers, Research & Drug Development, Understanding Rare Disease, PDF, Research, 5 Myths about the Orphan Drug Act
Advocates, Medical Professionals, Patient Organizations, Researchers, Students & Volunteers, Legislative Advocacy, Research & Drug Development, PDF, Research, Orphan Drug Costs and Expenditures
Advocates, Medical Professionals, Patient & Caregiver, Patient Organizations, Researchers, Students & Volunteers, Legislative Advocacy, Research & Drug Development, Infographic, Research, Orphan Drug Act Fact Sheet
